Modelling of multiple sclerosis: lessons learned in a non-human primate

被引:70
作者
t'Hart, BA [1 ]
Laman, JD
Bauer, J
Blezer, E
van Kooyk, Y
Hintzen, RQ
机构
[1] Biomed Primate Res Ctr, Dept Immunobiol, POB 3306, NL-2280 GH Rijswijk, Netherlands
[2] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[3] Univ Utrecht, Med Ctr, Imaging Sci Inst, Utrecht, Netherlands
[4] Free Univ Amsterdam, Med Ctr, Dept Cell Biol & Immunol, Amsterdam, Netherlands
[5] Med Univ Vienna, Brain Res Inst, Div Neuroimmunol, Vienna, Austria
关键词
D O I
10.1016/S1474-4422(04)00879-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The many, highly specific, biological therapies for immune-based diseases create a need for valid preclinical animal models. The wide immunological gap between human beings and laboratory mouse or rat models makes many disease models in these species invalid. In this review, we report a non-human-primate model of chronic multiple sclerosis (MS)-experimental autoimmune encephalitis (EAE) in the common marmoset (Callithrix jacchus)-that can help bridge this wide gap. The genetic and immunological similarity of marmosets and human beings and the clinical and neuropathological similarity of the EAE model to MS provide a unique experimental platform for research into basic immunopathogenetic mechanisms and for the development of more effective treatments for MS.
引用
收藏
页码:588 / 597
页数:10
相关论文
共 105 条
[1]
Heterologous immunity provides a potent barrier to transplantation tolerance [J].
Adams, AB ;
Williams, MA ;
Jones, TR ;
Shirasugi, N ;
Durham, MM ;
Kaech, SM ;
Wherry, EJ ;
Onami, T ;
Lanier, JG ;
Kokko, KE ;
Pearson, TC ;
Ahmed, R ;
Larsen, CP .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) :1887-1895
[2]
The common marmoset:: A new world primate species with limited Mhc class II variability [J].
Antunes, SG ;
de Groot, NG ;
Brok, H ;
Doxiadis, G ;
Menezes, AAL ;
Otting, N ;
Bontrop, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11745-11750
[3]
Interferon beta in multiple sclerosis [J].
Arnason, BGW .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 81 (01) :1-11
[4]
Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction [J].
Babbe, H ;
Roers, A ;
Waisman, A ;
Lassmann, H ;
Goebels, N ;
Hohlfeld, R ;
Friese, M ;
Schröder, R ;
Deckert, M ;
Schmidt, S ;
Ravid, R ;
Rajewsky, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :393-404
[5]
INDUCTION OF CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN BIOZZI MICE [J].
BAKER, D ;
ONEILL, JK ;
GSCHMEISSNER, SE ;
WILCOX, CE ;
BUTTER, C ;
TURK, JL .
JOURNAL OF NEUROIMMUNOLOGY, 1990, 28 (03) :261-270
[6]
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion [J].
Barnett, MH ;
Prineas, JW .
ANNALS OF NEUROLOGY, 2004, 55 (04) :458-468
[7]
Inflammation in the nervous system: The human perspective [J].
Bauer, J ;
Rauschka, H ;
Lassmann, H .
GLIA, 2001, 36 (02) :235-243
[8]
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event [J].
Berger, T ;
Rubner, P ;
Schautzer, F ;
Egg, R ;
Ulmer, H ;
Mayringer, I ;
Dilitz, E ;
Deisenhammer, F ;
Reindl, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :139-145
[9]
Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257
[10]
A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine [J].
Bond, A ;
Alavi, A ;
Axford, JS ;
Bourke, BE ;
Bruckner, FE ;
Kerr, MA ;
Maxwell, JD ;
Tweed, KJ ;
Weldon, MJ ;
Youinou, P ;
Hay, FC .
JOURNAL OF AUTOIMMUNITY, 1997, 10 (01) :77-85